- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05205889
A Mobile Intervention on Values in Chronic Pain Patients.
October 5, 2022 updated by: Jenny Riecke, Philipps University Marburg Medical Center
The study aims to test a mobile intervention on values and goals in chronic pain patients.
The cognitive behavioral intervention is a 10-day course in which participants complete a brief intervention each day (about 10-20 minutes a day).
The content of the intervention includes the definition of values; development of individualized values and personal value-oriented goals; and implementation of personal goals in every day life.
To assess the effectiveness of the intervention, we use a multiple baseline single case design.
Baseline measurements will be assessed daily between 10 and 17 days (the exact number will be randomized).
Daily measurements will continue during the intervention.
After the intervention, another post measurement will be collected.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hessen
-
Marburg, Hessen, Germany, 35032
- University of Marburg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Chronic, non-tumor related back pain (pain for at least 6 months)
- Ownership of a smartphone
- Numeric Rating Scale for pain result of ≥ 4
Exclusion Criteria:
- High cognitive impairment (e.g., intellectual disability)
- Currently in psychotherapeutic treatment
- Initiation of pain-focused treatment during the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mobile based values intervention for people with chronic pain
|
The protocol consists of 10 daily sessions, 10-20 Minutes each.
After each session participants will complete daily measures.
Participants will learn about values and a values based life.
Further they will identify their own values and are encouraged to set a goal to pursue those values.
Based on this, barriers to achieving goals are explained and a corresponding commitment will be made.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Pain intensity
Time Frame: Pain intensity is assessed daily from baseline to the end of treatment (resulting in 20-27 measuring time points)
|
Numerical Pain Rating Scale (NPRS) Minimum value: 0; Maximum value: 10 (higher scores indicate higher pain intensity)
|
Pain intensity is assessed daily from baseline to the end of treatment (resulting in 20-27 measuring time points)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in psychological well-being
Time Frame: Psychological well-being is assessed daily from baseline to the end of treatment (resulting in 20-27 measuring time points)
|
The five-item WHO Well-Being Index (WHO-5) Minimum value: 0; Maximum value 10 (range is adapted for the study; higher scores indicate higher psychological well-being)
|
Psychological well-being is assessed daily from baseline to the end of treatment (resulting in 20-27 measuring time points)
|
Change in chronic pain acceptance
Time Frame: Chronic Pain Acceptance is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
|
Chronic Pain Acceptance Questionnaire (CPAQ) Minimum value: 0; Maximum value: 10 (range is adapted for the study; higher scores indicate higher pain acceptance)
|
Chronic Pain Acceptance is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
|
Change in engaged living
Time Frame: Engaged Living is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
|
Engaged Living Scale (ELS) Minimum value: 0; Maximum value: 10 (range is adapted for the study; higher scores indicate higher engaged living)
|
Engaged Living is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
|
Change in pain catastrophizing
Time Frame: Pain Catastrophizing is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
|
Pain Catastrophizing Scale (PCS) Minimum value: 0; Maximum value: 10 (range is adapted for the study; higher scores indicate higher catastrophizing)
|
Pain Catastrophizing is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
|
Change in psychological flexibility
Time Frame: Psychological Flexibility is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
|
Acceptance and Action Questionnaire 2 (AAQ-2) Minimum value: 0; Maximum value: 10 (range is adapted for the study; higher scores indicate lower psychological flexibility)
|
Psychological Flexibility is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
|
Change in self-efficacy
Time Frame: Self-efficacy is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
|
Pain Self-efficacy Questionnaire (PSEQ) Minimum value: 0; Maximum value: 10 (range is adapted for the study; higher scores indicate higher self-efficacy)
|
Self-efficacy is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Winfried Rief, PhD, Philipps University Marburg Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 15, 2022
Primary Completion (Actual)
April 30, 2022
Study Completion (Actual)
May 31, 2022
Study Registration Dates
First Submitted
December 21, 2021
First Submitted That Met QC Criteria
January 12, 2022
First Posted (Actual)
January 25, 2022
Study Record Updates
Last Update Posted (Actual)
October 7, 2022
Last Update Submitted That Met QC Criteria
October 5, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SCA0222
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
IPD Plan Description
Data can be shared upon request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain Syndrome
-
Apurano Pharmaceuticals GmbHRecruitingPain | Lower Back Pain | Back Pain | Chronic Pain | Pain, Chronic | Chronic Pain Syndrome | Pain Syndrome | Lower Back Pain ChronicGermany
-
Apurano Pharmaceuticals GmbHRecruitingPain | Lower Back Pain | Back Pain | Chronic Pain | Pain, Chronic | Chronic Pain Syndrome | Pain Syndrome | Lower Back Pain ChronicGermany
-
Thomas Jefferson UniversityActive, not recruiting
-
Union de Gestion des Etablissements des Caisses...Mindmaze SACompletedRegional Pain Syndrome | Chronic Pain SyndromeFrance
-
University of UtahRecruitingChronic Pain | Chronic Pain Syndrome | Widespread Chronic PainUnited States
-
Alexandria UniversityActive, not recruitingChronic Pain SyndromeEgypt
-
Beth Israel Deaconess Medical CenterRecruiting
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States
-
Centre Hospitalier le MansRecruitingChronic Regional Pain SyndromeFrance
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
Clinical Trials on Mobile intervention on values and goals in patients with chronic pain.
-
Universiteit AntwerpenCompletedStudy Focus: Prescribing of DrugsBelgium
-
RANDBrigham and Women's Hospital; California Prevention Training CenterActive, not recruitingStigma, SocialUnited States
-
Bursa Yüksek İhtisas Education and Research HospitalCompletedIlioinguinal Nerve BlockTurkey
-
Baskent UniversityOkan UniversityCompleted
-
Akdeniz UniversityCompletedStroke, Ischemic | Self EfficacyTurkey
-
National Taipei University of Nursing and Health...Mackay Memorial HospitalNot yet recruiting
-
Istanbul University - Cerrahpasa (IUC)Recruiting
-
Kahramanmaras Sutcu Imam UniversityCompletedBack Pain | Anxiety | Comfort | Coronary Angiography PatientTurkey
-
Gaziler Physical Medicine and Rehabilitation Education...Completed
-
Ain Shams UniversityRecruiting